|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 20/21/20 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 22/20/22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 01/01/2020 |
Patty Meehan
ADM | Chief Administrative Officer | - | 01/01/2002 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | - | |
| Director/Board Member | 71 | 01/07/2019 | |
Kyle C. Kerbawy
CHM | Chairman | 79 | 01/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 34Cr | |
| +1.16% | -1.13% | -17.92% | +8.27% | 18TCr | |
| +0.02% | +4.24% | -19.82% | +16.53% | 12TCr | |
| -1.22% | +0.70% | +1.27% | +31.80% | 12TCr | |
| +2.29% | +17.36% | -41.94% | +9.49% | 9.33TCr | |
| -2.21% | -2.91% | +0.74% | +75.30% | 6.32TCr | |
| -1.06% | +1.75% | +13.50% | +80.00% | 5.57TCr | |
| -0.75% | +3.73% | +6.64% | -22.28% | 5.42TCr | |
| -1.13% | +0.00% | -12.25% | +31.02% | 4.41TCr | |
| +0.17% | +5.85% | -4.92% | -10.64% | 3.4TCr | |
| Average | -0.27% | +3.24% | -8.30% | +24.39% | 7.59TCr | |
| Weighted average by Cap. | -0.00% | +3.09% | -11.69% | +22.47% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 8.92Cr 7.97Cr 7.35Cr 6.67Cr 12Cr 847.07Cr 13Cr 89Cr 35Cr 443.33Cr 33Cr 33Cr 1.4TCr | 10Cr 9Cr 8.31Cr 7.54Cr 14Cr 956.94Cr 14Cr 100.02Cr 40Cr 500.83Cr 38Cr 37Cr 1.58TCr |
| Net income | -31.31L -27.96L -25.81L -23.42L -43.85L -30Cr -44.52L -3.11Cr -1.23Cr -16Cr -1.17Cr -1.15Cr -49Cr | 14.49L 12.93L 11.94L 10.83L 20.29L 14Cr 20.6L 1.44Cr 56.88L 7.2Cr 54.36L 53.21L 23Cr |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
